All In MedTech

Device Trial Radar · NCT07851402

Pediatric/Adolescent WatchPAT 400 Reliability Pilot Study

Diagnostic Accuracy and Inter-Rater Reliability of the WatchPAT® 400 Home Sleep Apnea Testing Device Compared to Attended In-Laboratory Polysomnography in Children and Adolescents Aged 6-18 Years

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

35

Planned (sponsor's estimate)

Start

Dec 1, 2026

Primary completion

Nov 30, 2027

Study completion Dec 1, 2028

Sponsor

Lead sponsor
Milton S. Hershey Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 1, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 6 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn whether a newer sleep-testing device gives results that closely match the standard overnight sleep study, in children and adolescents ages 6-18 who are being evaluated for possible sleep apnea. The main questions it aims to answer are: Does the new device (WatchPAT 400) give breathing and oxygen level results that agree with the standard overnight sleep study (polysomnography)? How reliably can two doctors, each looking at only one test's results, arrive at similar conclusions about a child's sleep apnea? Participants will: Have their regular, already-scheduled overnight sleep study performed exactly as usual Wear the WatchPAT 400 device (a small sensor on one finger, a wrist unit, and one adhesive patch on the chest) at the same time, during that same night Have both sets of results reviewed separately by two different study doctors Researchers will compare the results from the WatchPAT 400 device to the results from the standard sleep study to see how closely they agree, and how well the new device performs at detecting sleep apnea in children and teenagers.

Conditions

  • Pediatric Sleep Disordered Breathing
  • Obstructive Sleep Apnea

Interventions

  • WatchPAT 400Device

    A peripheral arterial tonometry (PAT)-based home sleep apnea testing device (Itamar Medical/ZOLL Itamar; FDA 510(k) K250460) consisting of a finger probe, wrist-worn recording unit, and adhesive chest sensor patch. The device is worn overnight, simultaneously with standard polysomnography, to generate an apnea-hypopnea index, respiratory disturbance index, sleep-stage estimates, and, in this device generation, a central apnea index and hypoxic burden measure, for comparison against polysomnography results.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Agreement Between WatchPAT 400-Derived Apnea-Hypopnea Index (pAHI) and Polysomnography-Derived Apnea-Hypopnea Index (AHI)Time frame: Single overnight recording (one night)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Penn State Hershey Medical Center

    Hummelstown, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.